AstraZeneca (GB:AZN) has released an update. Michel Demaré, the Non-Executive Chair of AstraZeneca, recently purchased 2,000 ordinary shares of ...
Despite the dominance of branding strategies, there is a growing counter-culture rejecting this form of consumer manipulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback